Physician profile
Jamie Speth
NPI 1659429116
$532.44
in general payments reported to CMS, 2019-2025
9 companies · $51.69 in 2025
The $51.69 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $84.50 · 2022: $18.23 · 2024: $378 · 2025: $51.69.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $430.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $429.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $136.01 | 2024 | Xiidra, Miebo |
| Apellis Pharmaceuticals, INC. | $131.49 | 2024 | Syfovre |
| Novartis Pharmaceuticals Corporation | $76.58 | 2021-2022 | |
| Harrow Eye, LLC | $72.27 | 2024 | |
| Amgen INC. | $41.18 | 2024-2025 | Tepezza |
| Dompe US, INC. | $30.39 | 2025 | Oxervate |
| Rxsight INC | $18.37 | 2024 | Light Adjustable Lens (Lal), Rxsight Injector Cartridge, Rxsight Injector Handpiece |
| Johnson & Johnson Vision Care, INC. | $13.79 | 2021 | |
| Sun Pharmaceutical Industries INC. | $12.36 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jamie Speth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.